X4 Pharmaceuticals
XFOR
Insider trades and stock quote 2024-2026
All insider trades at X4 Pharmaceuticals
| Date |
Type |
Insider |
Position |
Ø-Price |
Volume |
|
6/30/2026
|
Sell |
Kirske, David |
Chief Financial Officer |
$4.3 |
$36,428 |
|
5/12/2026
|
Sell |
Kirske, David |
Chief Financial Officer |
$4.3 |
$72,820 |
|
10/23/2025
|
Buy |
Craig, Adam R. |
Executive Chairman |
$2.9 |
$249,997 |
|
5/16/2025
|
Buy |
Baldry, Mark |
Chief Commercial Officer |
$2.5 |
$2,561 |
|
1/24/2025
|
Sell |
Arbet-Engels, Christophe |
Chief Medical Officer |
$0.5 |
$5,284 |
|
1/24/2025
|
Sell |
Dibiase, Mary |
Chief Operating Officer |
$0.5 |
$10,094 |
|
1/24/2025
|
Sell |
Baldry, Mark |
Chief Commercial Officer |
$0.5 |
$13,241 |
|
1/24/2025
|
Sell |
Mostafa, Adam S. |
Chief Financial Officer |
$0.5 |
$33,947 |
|
1/24/2025
|
Sell |
Ragan, Paula |
President and CEO |
$0.5 |
$34,719 |
|
11/15/2024
|
Buy |
Baldry, Mark |
Chief Commercial Officer |
$0.3 |
$4,598 |
|
11/15/2024
|
Sell |
Ragan, Paula |
President and CEO |
$0.4 |
$12,583 |
|
10/15/2024
|
Sell |
Ragan, Paula |
President and CEO |
$0.6 |
$17,926 |
|
10/7/2024
|
Sell |
Taveras, Arthur |
Chief Scientific Officer |
$0.6 |
$43,306 |
|
10/7/2024
|
Sell |
Dibiase, Mary |
Chief Operating Officer |
$0.6 |
$38,329 |
|
10/7/2024
|
Sell |
Ragan, Paula |
President and CEO |
$0.5 |
$131,522 |
|
10/7/2024
|
Sell |
Baldry, Mark |
Chief Commercial Officer |
$0.6 |
$6,506 |
|
10/7/2024
|
Sell |
Mostafa, Adam S. |
Chief Financial Officer |
$0.6 |
$126,901 |
|
9/9/2024
|
Sell |
Dibiase, Mary |
Chief Operating Officer |
$0.7 |
$1,738 |
All information without guarantee! No recommendation/consultation! © U.S. Securities and Exchange Commission (SEC)
Insidertrades in Telegram
Follow insider buying in real time via push in our Telegram channel.
Join now